{
  "input": {
    "mode": "score",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        }
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        }
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        }
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        }
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        }
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        }
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        }
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_vedolizumab",
          "name": "Vedolizumab"
        }
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        }
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        }
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        }
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_tazarotene",
          "name": "Tazarotene"
        }
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tazarotene",
          "type": "Drug",
          "label": "Tazarotene",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_cytokine_inhibition",
          "type": "Target",
          "label": "Cytokine Inhibition",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_immunomodulation_pathway",
          "type": "Pathway",
          "label": "Immunomodulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_skin_inflammation",
          "type": "Pathway",
          "label": "Skin Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "ph_reduction_inflam",
          "type": "Phenotype",
          "label": "Reduction in Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "ph_skin_clearance",
          "type": "Phenotype",
          "label": "Skin Clearance",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "Infliximab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "Infliximab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "Adverse Effects of Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "Adalimumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_adalimumab",
          "type": "Pathway",
          "label": "Adalimumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_adalimumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_apremilast",
          "type": "Target",
          "label": "Apremilast Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_apremilast",
          "type": "Pathway",
          "label": "Apremilast Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_apremilast",
          "type": "Phenotype",
          "label": "Adverse Effects of Apremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_acitretin",
          "type": "Target",
          "label": "Acitretin Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_acitretin",
          "type": "Pathway",
          "label": "Acitretin Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_acitretin",
          "type": "Phenotype",
          "label": "Adverse Effects of Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "Methotrexate Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "Methotrexate Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "Adverse Effects of Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cyclosporine",
          "type": "Target",
          "label": "Cyclosporine Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cyclosporine",
          "type": "Pathway",
          "label": "Cyclosporine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cyclosporine",
          "type": "Phenotype",
          "label": "Adverse Effects of Cyclosporine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_etanercept",
          "type": "Target",
          "label": "Etanercept Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_etanercept",
          "type": "Pathway",
          "label": "Etanercept Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_etanercept",
          "type": "Phenotype",
          "label": "Adverse Effects of Etanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_vedolizumab",
          "type": "Target",
          "label": "Vedolizumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_vedolizumab",
          "type": "Pathway",
          "label": "Vedolizumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_vedolizumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Vedolizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ustekinumab",
          "type": "Target",
          "label": "Ustekinumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ustekinumab",
          "type": "Pathway",
          "label": "Ustekinumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ustekinumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_secukinumab",
          "type": "Target",
          "label": "Secukinumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_secukinumab",
          "type": "Pathway",
          "label": "Secukinumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_secukinumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Secukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_brodalumab",
          "type": "Target",
          "label": "Brodalumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_brodalumab",
          "type": "Pathway",
          "label": "Brodalumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_brodalumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Brodalumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tazarotene",
          "type": "Target",
          "label": "Tazarotene Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_tazarotene",
          "type": "Pathway",
          "label": "Tazarotene Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_tazarotene",
          "type": "Phenotype",
          "label": "Adverse Effects of Tazarotene",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Brodalumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Tazarotene",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_infliximab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "针对细胞因子的直接抑制作用"
        },
        {
          "source": "t_cytokine_inhibition",
          "target": "p_immunomodulation_pathway",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与免疫调节通路的关系"
        },
        {
          "source": "p_immunomodulation_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通过免疫调节影响该疾病"
        },
        {
          "source": "drug_adalimumab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "属于抗细胞因子类药物"
        },
        {
          "source": "drug_apremilast",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过抑制炎症细胞因子起效"
        },
        {
          "source": "drug_acitretin",
          "target": "p_skin_inflammation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "可能通过减轻皮肤炎症作用"
        },
        {
          "source": "p_skin_inflammation",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "直接影响该皮肤病"
        },
        {
          "source": "drug_methotrexate",
          "target": "p_skin_inflammation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "常用抗风湿药物，影响皮肤炎症"
        },
        {
          "source": "drug_cyclosporine",
          "target": "p_immunomodulation_pathway",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通过免疫抑制作用产生效果"
        },
        {
          "source": "drug_etanercept",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "另一种抗细胞因子药物"
        },
        {
          "source": "drug_vedolizumab",
          "target": "p_immunomodulation_pathway",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "调整免疫系统以应对炎症"
        },
        {
          "source": "drug_ustekinumab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "针对特定细胞因子的抗体治疗"
        },
        {
          "source": "drug_secukinumab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "以细胞因子为靶点的治疗机制"
        },
        {
          "source": "drug_brodalumab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "发挥抑制作用"
        },
        {
          "source": "drug_tazarotene",
          "target": "p_skin_inflammation",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "具有皮肤有效性"
        },
        {
          "source": "p_skin_inflammation",
          "target": "ph_skin_clearance",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "改善皮肤状况"
        },
        {
          "source": "p_immunomodulation_pathway",
          "target": "ph_reduction_inflam",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "减少炎症反应的支持证据"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp_adalimumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_adalimumab",
          "target": "n_adv_adalimumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_adalimumab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_apremilast",
          "target": "n_ot_apremilast",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_apremilast",
          "target": "n_rp_apremilast",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_apremilast",
          "target": "n_adv_apremilast",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_apremilast",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_acitretin",
          "target": "n_ot_acitretin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_acitretin",
          "target": "n_rp_acitretin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_acitretin",
          "target": "n_adv_acitretin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_acitretin",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_cyclosporine",
          "target": "n_ot_cyclosporine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_cyclosporine",
          "target": "n_rp_cyclosporine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_cyclosporine",
          "target": "n_adv_cyclosporine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_cyclosporine",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_etanercept",
          "target": "n_ot_etanercept",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_etanercept",
          "target": "n_rp_etanercept",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_etanercept",
          "target": "n_adv_etanercept",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_etanercept",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_vedolizumab",
          "target": "n_ot_vedolizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_vedolizumab",
          "target": "n_rp_vedolizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_vedolizumab",
          "target": "n_adv_vedolizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_vedolizumab",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_ot_ustekinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_ustekinumab",
          "target": "n_rp_ustekinumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_ustekinumab",
          "target": "n_adv_ustekinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_ustekinumab",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_ot_secukinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_secukinumab",
          "target": "n_rp_secukinumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_secukinumab",
          "target": "n_adv_secukinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_secukinumab",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_ot_brodalumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_brodalumab",
          "target": "n_rp_brodalumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_brodalumab",
          "target": "n_adv_brodalumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_brodalumab",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_tazarotene",
          "target": "n_ot_tazarotene",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_tazarotene",
          "target": "n_rp_tazarotene",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_tazarotene",
          "target": "n_adv_tazarotene",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_tazarotene",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        }
      ],
      "round_index": 1
    },
    "history": {
      "round": 1,
      "last_scores": []
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65
    },
    "heuristic_priors": []
  },
  "output": {
    "scoring_summary": [
      {
        "hypothesis_id": "H1",
        "score": 0.78,
        "components": {
          "mechanism_fit": 0.85,
          "class_prior": 0.75,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.08
        },
        "graph_signals": {
          "support_weight": 2.3,
          "contradiction_weight": 1.6,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Infliximab Efficacy",
              "pro": [
                "drug_infliximab"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "通过细胞因子抑制机制与疾病有良好关联"
          ],
          "indication_plausibility": [
            "近期对该药的多项研究支持其用于处理此类皮肤病"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.75,
        "components": {
          "mechanism_fit": 0.82,
          "class_prior": 0.75,
          "pk_pd_feasibility": 0.68,
          "indication_plausibility": 0.75,
          "safety_risk": 0.15,
          "graph_bonus": 0.12,
          "conflict_penalty": 0.08
        },
        "graph_signals": {
          "support_weight": 2.2,
          "contradiction_weight": 1.6,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adalimumab Efficacy",
              "pro": [
                "drug_adalimumab"
              ],
              "con": [
                "n_adv_adalimumab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "机制证明能有效抑制相关细胞因子"
          ],
          "indication_plausibility": [
            "临床数据一致表明其疗效"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.72,
        "components": {
          "mechanism_fit": 0.78,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.66,
          "indication_plausibility": 0.72,
          "safety_risk": 0.18,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 2.0,
          "contradiction_weight": 1.6,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Apremilast Efficacy",
              "pro": [
                "drug_apremilast"
              ],
              "con": [
                "n_adv_apremilast"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "通过抑制细胞因子有效控制炎症反应"
          ],
          "indication_plausibility": [
            "其临床应用在类似病症中表现出积极效果"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.7,
        "components": {
          "mechanism_fit": 0.76,
          "class_prior": 0.68,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.7,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.9,
          "contradiction_weight": 1.6,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Acitretin Efficacy",
              "pro": [
                "drug_acitretin"
              ],
              "con": [
                "n_adv_acitretin"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "抗炎机制有效在皮肤疾病中起作用"
          ],
          "indication_plausibility": [
            "相关疗效在临床中得到了一定证实"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.68,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.65,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.68,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.12
        },
        "graph_signals": {
          "support_weight": 1.8,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Methotrexate Efficacy",
              "pro": [
                "drug_methotrexate"
              ],
              "con": [
                "n_adv_methotrexate"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "作为经典药物，通过多种机制起效"
          ],
          "indication_plausibility": [
            "在不同患者中的疗效存在较大变异"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.66,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.66,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.12
        },
        "graph_signals": {
          "support_weight": 1.7,
          "contradiction_weight": 1.75,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Cyclosporine Efficacy",
              "pro": [
                "drug_cyclosporine"
              ],
              "con": [
                "n_adv_cyclosporine"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "伴随抗风湿作用界限的药物"
          ],
          "indication_plausibility": [
            "适用范围较窄且疗效不一"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.65,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.58,
          "pk_pd_feasibility": 0.54,
          "indication_plausibility": 0.65,
          "safety_risk": 0.28,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.12
        },
        "graph_signals": {
          "support_weight": 1.6,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Etanercept Efficacy",
              "pro": [
                "drug_etanercept"
              ],
              "con": [
                "n_adv_etanercept"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "作为TNF-α抑制剂用于多种炎症疾病"
          ],
          "indication_plausibility": [
            "用于特定皮肤病的证据日益增多"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.62,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.62,
          "safety_risk": 0.32,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.14
        },
        "graph_signals": {
          "support_weight": 1.5,
          "contradiction_weight": 1.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Vedolizumab Efficacy",
              "pro": [
                "drug_vedolizumab"
              ],
              "con": [
                "n_adv_vedolizumab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "通过内源性免疫反应实现作用"
          ],
          "indication_plausibility": [
            "对特定表型的影响最小化"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.6,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.52,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.6,
          "safety_risk": 0.35,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.16
        },
        "graph_signals": {
          "support_weight": 1.4,
          "contradiction_weight": 1.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Ustekinumab Efficacy",
              "pro": [
                "drug_ustekinumab"
              ],
              "con": [
                "n_adv_ustekinumab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "通过对特定细胞因子的调节作用"
          ],
          "indication_plausibility": [
            "证据仍未完全确定其在该坏境下的表现"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.55,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.55,
          "safety_risk": 0.4,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.18
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 1.9,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "Secukinumab Efficacy",
              "pro": [
                "drug_secukinumab"
              ],
              "con": [
                "n_adv_secukinumab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "对细胞因子的特定抑制能力表现良好"
          ],
          "indication_plausibility": [
            "新近的临床试验提供了一定支持"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.52,
        "components": {
          "mechanism_fit": 0.48,
          "class_prior": 0.45,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.5,
          "safety_risk": 0.45,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 1.2,
          "contradiction_weight": 1.9,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "Brodalumab Efficacy",
              "pro": [
                "drug_brodalumab"
              ],
              "con": [
                "n_adv_brodalumab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "在调节细胞因子方表现概率因功能性得分"
          ],
          "indication_plausibility": [
            "临床数据局限，难以全方位评估疗效"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.48,
        "components": {
          "mechanism_fit": 0.45,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.35,
          "indication_plausibility": 0.48,
          "safety_risk": 0.5,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.1,
          "contradiction_weight": 2.0,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "Tazarotene Efficacy",
              "pro": [
                "drug_tazarotene"
              ],
              "con": [
                "n_adv_tazarotene"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "与其他更强效的药物相比，机制相对较弱"
          ],
          "indication_plausibility": [
            "表明有限的适应症支持"
          ]
        },
        "confidence": "low",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H4",
      "H5",
      "H6",
      "H7",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "delta_since_last_round": null,
    "stop_decision": {
      "should_stop": false,
      "reasons": []
    }
  }
}